Warfarin Sensitivity Genotyping
Use of Mayo’s recently introduced warfarin sensitivity genotyping test in the identification of patients at risk of warfarin-associated bleeding is discussed.
- Dr. Dennis J. O’Kane, Co-Director of the Nucleotide Polymorphism Laboratory, in the Division of Clinical Biochemistry & Immunology at Mayo Clinic
See Warfarin: Genotyping
and improving dosing in the August
2008 issue of Communiqué.
Warfarin genotyping is just one of the tests that Mayo Medical Laboratories offers to identify those patients with abnormal drug metabolism. Testing is also available for the cytochrome P450 polymorphisms:
- Cytochrome P450 2C19 Genotype
- Cytochrome P450 2C9 Genotype
Forward to a Colleague
If you have questions, e-mail